and get StockInvest.us Premium Subscription for FREE
Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Catalyst Pharmaceuticals Stock Price (Quote) NASDAQ:CPRX
$7.40 ( 4.82% ) Tuesday, 5th Jul 2022
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $6.15 | $7.42 | Tuesday, 5th Jul 2022 CPRX stock ended at $7.40. This is 4.82% more than the trading day before Friday, 1st Jul 2022. During the day the stock fluctuated 7.07% from a day low at $6.93 to a day high of $7.42. |
| 90 days | $6.15 | $8.64 | |
| 52 weeks | $4.81 | $8.65 |
Historical Catalyst Pharmaceuticals prices
| Date | Open | High | Low | Close | Volume |
| 2022-07-05 | $6.97 | $7.42 | $6.93 | $7.40 | 1 535 318 |
| 2022-07-01 | $6.99 | $7.10 | $6.87 | $7.06 | 1 222 384 |
| 2022-06-30 | $6.85 | $7.11 | $6.85 | $7.01 | 1 256 997 |
| 2022-06-29 | $6.91 | $6.98 | $6.81 | $6.95 | 751 825 |
| 2022-06-28 | $7.19 | $7.23 | $6.82 | $6.88 | 984 915 |
| 2022-06-27 | $6.68 | $7.13 | $6.63 | $7.10 | 888 920 |
| 2022-06-24 | $6.74 | $6.79 | $6.43 | $6.64 | 3 760 773 |
| 2022-06-23 | $6.59 | $6.72 | $6.47 | $6.69 | 1 285 507 |
| 2022-06-22 | $6.43 | $6.72 | $6.38 | $6.57 | 678 439 |
| 2022-06-21 | $6.55 | $6.76 | $6.54 | $6.56 | 1 056 023 |
| 2022-06-17 | $6.38 | $6.68 | $6.29 | $6.45 | 1 802 994 |
| 2022-06-16 | $6.36 | $6.43 | $6.25 | $6.38 | 1 013 310 |
| 2022-06-15 | $6.42 | $6.59 | $6.30 | $6.51 | 1 458 775 |
| 2022-06-14 | $6.25 | $6.39 | $6.20 | $6.36 | 1 106 529 |
| 2022-06-13 | $6.50 | $6.60 | $6.15 | $6.23 | 1 226 335 |
| 2022-06-10 | $6.52 | $6.80 | $6.52 | $6.68 | 1 230 451 |
| 2022-06-09 | $6.93 | $7.03 | $6.63 | $6.65 | 731 518 |
| 2022-06-08 | $7.10 | $7.21 | $6.95 | $6.96 | 881 863 |
| 2022-06-07 | $7.00 | $7.22 | $6.95 | $7.17 | 573 416 |
| 2022-06-06 | $7.41 | $7.41 | $6.92 | $7.02 | 1 036 354 |
| 2022-06-03 | $7.08 | $7.37 | $7.08 | $7.36 | 799 075 |
| 2022-06-02 | $6.99 | $7.16 | $6.93 | $7.09 | 547 746 |
| 2022-06-01 | $7.25 | $7.30 | $6.92 | $7.03 | 1 161 502 |
| 2022-05-31 | $7.31 | $7.42 | $7.10 | $7.20 | 976 054 |
| 2022-05-27 | $7.07 | $7.38 | $6.94 | $7.33 | 965 591 |
| 2022-05-26 | $6.89 | $7.07 | $6.82 | $7.02 | 768 943 |
| 2022-05-25 | $6.84 | $6.94 | $6.62 | $6.88 | 998 434 |
| 2022-05-24 | $6.81 | $6.96 | $6.73 | $6.87 | 841 734 |
| 2022-05-23 | $7.16 | $7.22 | $6.89 | $6.92 | 1 016 148 |
| 2022-05-20 | $6.94 | $7.17 | $6.78 | $7.06 | 1 040 579 |
| 2022-05-19 | $6.75 | $7.01 | $6.72 | $6.92 | 1 057 363 |
| 2022-05-18 | $7.21 | $7.21 | $6.73 | $6.82 | 1 073 509 |
| 2022-05-17 | $7.12 | $7.22 | $6.96 | $7.17 | 1 830 437 |
| 2022-05-16 | $6.86 | $7.10 | $6.69 | $7.00 | 1 146 764 |
| 2022-05-13 | $6.74 | $6.94 | $6.71 | $6.91 | 1 543 187 |
| 2022-05-12 | $6.51 | $6.76 | $6.43 | $6.65 | 1 976 890 |
| 2022-05-11 | $6.84 | $6.87 | $6.30 | $6.51 | 1 849 155 |
| 2022-05-10 | $6.64 | $7.02 | $6.50 | $6.93 | 2 710 241 |
| 2022-05-09 | $7.10 | $7.26 | $6.49 | $6.54 | 2 996 751 |
| 2022-05-06 | $7.42 | $7.51 | $7.17 | $7.22 | 1 083 499 |
| 2022-05-05 | $7.75 | $7.81 | $7.38 | $7.53 | 1 285 290 |
| 2022-05-04 | $7.79 | $7.89 | $7.40 | $7.82 | 1 273 863 |
| 2022-05-03 | $7.82 | $7.83 | $7.63 | $7.73 | 752 978 |
| 2022-05-02 | $7.62 | $7.83 | $7.57 | $7.81 | 1 299 173 |
| 2022-04-29 | $7.79 | $7.98 | $7.54 | $7.62 | 1 081 827 |
| 2022-04-28 | $7.90 | $8.03 | $7.38 | $7.82 | 1 087 892 |
| 2022-04-27 | $7.84 | $8.03 | $7.75 | $7.79 | 984 770 |
| 2022-04-26 | $8.19 | $8.23 | $7.83 | $7.85 | 1 301 348 |
| 2022-04-25 | $7.96 | $8.25 | $7.91 | $8.25 | 793 851 |
| 2022-04-22 | $8.22 | $8.28 | $8.03 | $8.05 | 867 600 |
Catalyst Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies for people with rare debilitating diseases. Its lead product candidate is Firdapse, a proprietary form of amifampridine phosphate, which completed Phase III clinical trial for the treatment of patients with Lambert-Eaton Myasthenic syndrome; and is in small blinded clinical trial to treat Congenital Myasthenic syndromes, as w... ![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
